CAS RN: 52817-13-7
6-Bromochromone-3-carbonitrile
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
≥98% (1)
In stock only
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20250920
200mg / 1g / 5g
Confirm by inquiry
Shanghai 8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥98%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 52817-13-7
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥98%
0
Out of Stock
Shenzhen
Inquiry
52817-13-7 / 6-bromo-4-oxochromene-3-carbonitrile
Standard CAS: 52817-13-7
Multi CAS: Yes
Basic Information
copy
CAS
52817-13-7 copy
Multi CAS
Yes copy
Molecular Formula
BC10H4O2Rn copy
Molecular Weight
250.050000 copy
Exact Mass
248.942540 copy
InChI
InChI=1S/C10H4BrNO2/c11-7-1-2-9-8(3-7)10(13)6(4-12)5-14-9/h1-3,5H copy
InChIKey
MGVVCEKLWMZFLS-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
14 copy
Aromatic heavy atom count
10 copy
H-bond acceptors
3 copy
Molar refractivity
54.9 copy
TPSA
54 copy
LogP / Solubility
WLOGP
2.43 copy
MLOGP
2.14 copy
XLogP3
2.2 copy
Consensus LogP
2.26 copy
Log S (ESOL)
-3.45 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.36 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.3 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.52 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
1.5 copy